CFTR modulator therapy has demonstrated its efficacy and beneficial effect on restoration of CFTR function for approximately 90% CF genotypes (Wainwright et al., 2015; Rowe et al., 2017; Davies et al., 2018; Keating et al., 2018; Middleton et al., 2019). The gene discussed is CFTR; the disease is cystic fibrosis.